Southern Capital Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$423K Hold
1,168
0.18% 51
2026
Q1
$411K Hold
1,168
0.19% 53
2025
Q4
$382K Hold
1,168
0.18% 54
2025
Q3
$330K Hold
1,168
0.15% 63
2025
Q2
$326K Hold
1,168
0.17% 59
2025
Q1
$364K Hold
1,168
0.2% 54
2024
Q4
$304K Hold
1,168
0.17% 53
2024
Q3
$376K Sell
1,168
-246
-17% -$80.5K 0.21% 47
2024
Q2
$442K Sell
1,414
-22
-2% -$6.46K 0.27% 41
2024
Q1
$408K Buy
1,436
+740
+106% +$217K 0.25% 46
2023
Q4
$201K Buy
+696
New +$190K 0.14% 67
2023
Q1
Sell
-814
Closed -$214K 74
2022
Q4
$214K Buy
+814
New +$218K 0.17% 69
2022
Q3
Sell
-863
Closed -$210K 67
2022
Q2
$210K Sell
863
-6
-0.7% -$1.47K 0.17% 63
2022
Q1
$210K Buy
+869
New +$200K 0.14% 75

Other funds holding AMGN

Southern Capital Advisors's AMGN Position: Q2 2026 in Review

Southern Capital Advisors held its Amgen (AMGN) position steady in Q2 2026 at 1,168 shares worth $423K. The position accounts for 0.18% of the portfolio, ranked #51.

Southern Capital Advisors first reported a position in AMGN in Q1 2022 and has held it in 14 quarters since. The position peaked at $442K in Q2 2024. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Southern Capital Advisors held 1,168 shares of Amgen worth $423K as of Q2 2026.
  • Southern Capital Advisors left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.18% of Southern Capital Advisors's portfolio in Q2 2026, its #51 holding.
  • Southern Capital Advisors first reported a position in Amgen in Q1 2022 and has held it in 14 quarters since.
  • Southern Capital Advisors's Amgen position peaked at $442K in Q2 2024.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Southern Capital Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.